May 9 |
Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
|
May 2 |
Outlook Therapeutics® to Present at the Retina World Congress 2024
|
Apr 29 |
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
|
Apr 26 |
Outlook Therapeutics files to sell 2.78M shares of common stock for holders
|
Apr 26 |
Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors
|
Apr 15 |
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
|
Apr 15 |
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
|
Apr 10 |
Insiders are Piling into These 10 Healthcare Stocks in 2024
|
Apr 1 |
Insiders Buying Outlook Therapeutics And 2 Other Stocks
|
Mar 31 |
Outlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up For Possible ONS-5010 Approval
|